Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.46 |
| ▸ | CA2 | P00918 | 8/20 | 0.46 |
| ▸ | CA9 | Q16790 | 7/20 | 0.46 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 6/20 | 0.45 |
| ▸ | PDE4A | P27815 | 2/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25289489 | 1.00 | CA1 (0.46) | CA1CA2CA9CA12PDE4B | |
| SCHEMBL25235327 | 0.85 | CA1 (0.50) | CA1CA2CA9CA12PDE4B | |
| SCHEMBL30457101 | 0.85 | CA1 (0.50) | CA1CA2CA9CA12PDE4B | |
| SCHEMBL30394598 | 0.84 | PDE4B (0.49) | PDE4BKDM1AAPP | |
| SCHEMBL17002842 | 0.84 | PDE4B (0.49) | PDE4BKDM1AAPP | |
| SCHEMBL17002845 | 0.84 | PDE4B (0.49) | PDE4BKDM1AAPP | |
| SCHEMBL15805111 | 0.82 | PDE4B (0.62) | CA1CA2CA9CA12PDE4B | |
| SCHEMBL17259138 | 0.82 | PDE4B (0.62) | CA1CA2CA9CA12PDE4B | |
| SCHEMBL15799414 | 0.82 | PDE4B (0.62) | CA1CA2CA9CA12PDE4B | |
| SCHEMBL15799413 | 0.82 | PDE4B (0.62) | CA1CA2CA9CA12PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4448508-A1 | BENZOTHIOPHENE DERIVATIVES AS RXFP1 AGONISTS | Bristol-Myers Squibb Company (US) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023114823-A1 | BENZOTHIOPHENE DERIVATIVES AS RXFP1 AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-06-22 | — | — | WO | disclosed |